title: Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation.
authors.forename: X A
authors.initials: XA
authors.lastname: Zervos
authors.forename: D
authors.initials: D
authors.lastname: Weppler
authors.forename: G P
authors.initials: GP
authors.lastname: Fragulidis
authors.forename: M B
authors.initials: MB
authors.lastname: Torres
authors.forename: J R
authors.initials: JR
authors.lastname: Nery
authors.forename: M F
authors.initials: MF
authors.lastname: Khan
authors.forename: A D
authors.initials: AD
authors.lastname: Pinna
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: J
authors.initials: J
authors.lastname: Miller
authors.forename: K R
authors.initials: KR
authors.lastname: Reddy
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
mesh_terms: D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000503:physiopathology / Q000601:surgery* / Q000821:virology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D008113:Liver Neoplasms / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis; D012008:Recurrence; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D012367:RNA, Viral; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone